This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Rating strategy
Novo Nordisk considers the maintenance of two investment grade ratings an important target; the present rating and outlook from Moody's and Standard & Poor's are shown below.
| Agency | Rating | Outlook |
| S&P | A+ | Stable |
| Moody's | A1 | Stable |
Novo Nordisk’s goal is to ensure that rating agencies continue to be comfortable with Novo Nordisk’s strategy and performance. The company's strategy is to maintain liquidity well within the comfort level of the agencies. Annual review meetings are arranged with the Novo Nordisk management, and Novo Nordisk keep in regular contact with the rating analysts.









